Intravenous abatacept in Japanese patients with polyarticular-course juvenile idiopathic arthritis: results from a phase III open-label study

被引：0

作者：

Ryoki Hara

Hiroaki Umebayashi

Syuji Takei

Nami Okamoto

Naomi Iwata

Yuichi Yamasaki

Yasuo Nakagishi

Toshitaka Kizawa

Ichiro Kobayashi

Tomoyuki Imagawa

Noriko Kinjo

Norihito Amano

Yoko Takahashi

Masaaki Mori

Yasuhiko Itoh

Shumpei Yokota

机构：

[1] Yokohama City University School of Medicine,Department of Pediatrics

[2] Miyagi Children’s Hospital,Department of General Pediatrics

[3] 4-3-17 Ochiai,Department of Pediatrics

[4] Kagoshima University Medical and Dental Hospital,Department of Pediatrics

[5] Graduate School of Medicine,Department of Immunology and Infectious Diseases

[6] Osaka Medical College,Department of Pediatric Rheumatology

[7] Aichi Children’s Health and Medical Center,Department of Pediatrics

[8] Hyogo Prefectural Kobe Children’s Hospital,Department of Pediatrics

[9] Japan Community Health Care Organization Sapporo Hokushin Hospital,Division of Infection, Immunology and Rheumatology

[10] Hokkaido University Hospital,Department of Pediatrics

[11] Kanagawa Prefectural Hospital Organisation Kanagawa Children’s Medical Center,Bristol

[12] University of the Ryukyus Hospital,Myers Squibb K.K

[13] 6-5-1 Nishi-Shinjuku,Department of Lifetime Clinical Immunology, Graduate School of Medical and Dental Sciences

[14] Tokyo Medical and Dental University,Department of Pediatrics

[15] Graduate School of Medicine,undefined

[16] Nippon Medical School,undefined

[17] Fuji Toranomon Orthopaedics Hospital,undefined

来源：

Pediatric Rheumatology | / 17卷

关键词：

Abatacept; Disease-modifying anti-rheumatic drugs (DMARDs); Japanese; Juvenile idiopathic arthritis; Pharmacokinetics;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

下载

共 50 条

[31] Neutropenia With Tocilizumab Treatment Is Not Associated With Increased Infection Risk in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis
De Benedetti, Fabrizio
Rubio-Perez, Nadina
Salazar, Carolina Duarte
Goodman, Steven
Job-Deslandre, Chantal
Joos, Rik
Kone-Paut, Isabelle
Minden, Kirsten
Onel, Karen
Porter-Brown, Benjamin
Bharucha, Kamal
Wang, Jianmei
Martini, Alberto
Lovell, Daniel J.
Brunner, Hermine I.
ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S67 - S68
[32] EFFICACY AND SAFETY OF TOCILIZUMAB IN POLYARTICULAR-COURSE JUVENILE IDIOPATHIC ARTHRITIS: 2 YEAR DATA FROM CHERISH
Baildam, Eileen
Ramanan, Athimalaipet
Woo, Patricia
Brunner, Hermine
Ruperto, Nicola
Zuber, Zbyszek
Cuttica, Ruben J.
Xavier, Ricardo
Penades, Inmaculada Calvo
Rubio-Perez, Nadina
Alexeeva, Ekaterina
Chasnyk, Vyacheslav
Chavez, Jose
Horneff, Gerd
Opoka-Winiarska, Violetta
Quartier, Pierre
Spindler, Alberto
Keane, Caroline
Bharucha, Kamal
Wang, Jianmei
Lovell, Daniel J.
Martini, Alberto
De Benedetti, Fabrizio
RHEUMATOLOGY, 2014, 53 : 52 - 53
[33] Efficacy and Safety of Tocilizumab in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: 2-Year Data From CHERISH
Brunner, Hermine
Ruperto, Nicolino
Zuber, Zbigniew
Cuttica, Ruben J.
Xavier, Ricardo
Calvo, Inmaculada
Rubio, Nadina
Alekseeva, Ekaterina
Chasnyk, Vyacheslav
Chavez, Jose
Horneff, Gerd
Opoka-Winiarska, Violetta
Quartier, Pierre
Spindler, Alberto
Keane, Caroline
Bharucha, Kamal N.
Wang, Jianmei
Lovell, Daniel J.
Martini, Alberto
De Benedetti, Fabrizio
ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S5 - S6
[34] Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension
Ruperto, Nicolino
Lovell, Daniel J.
Cuttica, Ruben
Woo, Patricia
Meiorin, Silvia
Wouters, Carine
Silverman, Earl D.
Balogh, Zsolt
Henrickson, Michael
Davidson, Joyce
Foeldvari, Ivan
Imundo, Lisa
Simonini, Gabriele
Oppermann, Joachim
Xu, Stephen
Shen, Yaung-Kaung
Visvanathan, Sudha
Fasanmade, Adedigbo
Mendelsohn, Alan
Martini, Alberto
Giannini, Edward H.
ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (04) : 718 - 722
[35] Maintenance of antibody response to diphtheria/tetanus vaccine in patients aged 2–5 years with polyarticular-course juvenile idiopathic arthritis receiving subcutaneous abatacept
Hermine I. Brunner
Nikolay Tzaribachev
Gabriel Vega Cornejo
Rik Joos
Elisabeth Gervais
Rolando Cimaz
Inmaculada Calvo Penadés
Rubén Cuttica
Thomas Lutz
Pierre Quartier
Yash Gandhi
Marleen Nys
Robert Wong
Alberto Martini
Daniel J. Lovell
Nicolino Ruperto
Pediatric Rheumatology, 18
[36] Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis - Interim results from an ongoing multicenter, open-label, extended-treatment trial
Lovell, DJ
Giannini, EH
Reiff, A
Jones, OY
Schneider, R
Olson, JC
Stein, LD
Gedalia, A
Ilowite, NT
Wallace, CA
Lange, M
Finck, BK
Burge, DJ
ARTHRITIS AND RHEUMATISM, 2003, 48 (01): : 218 - 226
[37] Abatacept is well tolerated in a double-blind, randomised withdrawal study, with an open-label extension, in patients with juvenile idiopathic arthritis
Quartier, P.
Ruperto, N.
Lovell, D. J.
Paz, E.
Rubio-Perez, N.
Covucci, A.
Segal, L.
Giannini, E. H.
Martini, A.
RHEUMATOLOGY, 2008, 47 : II3 - II3
[38] Efficacy and Safety Of Tocilizumab In Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: 2-Year Data From Cherish.
Brunner, Hermine I.
Ruperto, Nicolino
Zuber, Zbigniew
Cuttica, Ruben J.
Xavier, Ricardo
Calvo, Inmaculada
Rubio, Nadina
Alekseeva, Ekaterina
Chasnyk, Vyacheslav
Chavez, Jose
Horneff, Gerd
Opoka-Winiarska, Violetta
Quartier, Pierre
Spindler, Alberto
Keane, Caroline
Bharucha, Kamal N.
Wang, Jianmei
Lovell, Daniel J.
Martini, Alberto
De Benedetti, Fabrizio
ARTHRITIS AND RHEUMATISM, 2013, 65 : S335 - S335
[39] Maintenance of antibody response to diphtheria/tetanus vaccine in patients aged 2-5 years with polyarticular-course juvenile idiopathic arthritis receiving subcutaneous abatacept
Brunner, Hermine I.
Tzaribachev, Nikolay
Cornejo, Gabriel Vega
Joos, Rik
Gervais, Elisabeth
Cimaz, Rolando
Calvo Penades, Inmaculada
Cuttica, Ruben
Lutz, Thomas
Quartier, Pierre
Gandhi, Yash
Nys, Marleen
Wong, Robert
Martini, Alberto
Lovell, Daniel J.
Ruperto, Nicolino
PEDIATRIC RHEUMATOLOGY, 2020, 18 (01)
[40] A randomized, multi-center, blinded, placebo-controlled study with an open-label run-in period to evaluate anakinra in polyarticular-course juvenile rheumatoid arthritis.
Ilowitel, N.
Reiff, A.
Rudge, S.
Punaro, M.
Martin, A.
Allen, R.
Harville, T.
Bevirt, T.
Aras, G.
Appleton, B.
ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S327 - S328

← 1 2 3 4 5 →